Familial conformational diseases and dementias

Human Mutation

Volumn 20, Issue 1, 2002, Pages 1-14

  Crowther, Damian C ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

1 antitrypsin; AD; Alzheimer disease; Amyloid; CJD; Conformational disease; Creutzfeldt Jakob; HD; Huntington disease; Neuroserpin; Parkinson disease; PD; PI; PI12; PRNP; Protein aggregation; PSEN1; PSEN2; SERPINAI

Indexed keywords

GENE PRODUCT; PROTEIN NEUROSERPIN; SERINE PROTEINASE INHIBITOR; UNCLASSIFIED DRUG;

ALPHA 1 ANTITRYPSIN DEFICIENCY; ALZHEIMER DISEASE; BRAIN DISEASE; CELL INCLUSION; DEMENTIA; DISEASE ASSOCIATION; FAMILIAL DISEASE; GENE MUTATION; HUMAN; HUNTINGTON CHOREA; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN CONFORMATION; PROTEIN FAMILY; PROTEIN INTERACTION; REVIEW; TISSUE INJURY;

ALPHA 1-ANTITRYPSIN; BRAIN DISEASES; DEMENTIA; FAMILY HEALTH; HUMANS; MUTATION; NEUROPEPTIDES; PROTEIN CONFORMATION; SERPINS;

EID: 0036301160     PISSN: 10597794     EISSN: None     Source Type: Journal    
DOI: 10.1002/humu.10100     Document Type: Review

References (155)

1. Structure and expression of the Huntington's disease gene: Evidence against simple inactivation due to an expanded CAG repeat
2. 436ØThr) results in nonsubstrate-like behavior and in polymerization of the molecule
3. Association of an extended haplotype in the tau gene with progressive supranuclear palsy
4. Intranuclear neuronal inclusions in Huntington's disease and dentatorubral and pallidoluysian atrophy: Correlation between the density of inclusions and IT15 CAG triplet repeat length
5. Review: Immunoglobulin light chain amyloidosis - The archetype of structural and pathogenic variability
6. Hereditary renal amyloidosis associated with a mutant fibrinogen alpha-chain
7. A new human hereditary amyloidosis: The result of a stop-codon mutation in the apolipoprotein aii gene
8. Synchrotron X-ray studies suggest that the core of the transthyretin amyloid fibril is a continuous beta-sheet helix
9. Hereditary hepatic and systemic amyloidosis caused by a new deletion/insertion mutation in the apolipoprotein AI gene
10. Cognitive deficits associated with a recently reported familial neurodegenerative disease: Familial encephalopathy with neuroserpin inclusion bodies
11. Thromboembolic disease due to thermolabile conformational changes of antithrombin Rouen VI (187 AsnØAsp)
12. Frontotemporal dementia and corticobasal degeneration in a family with a P301S mutation in tau
13. Early-onset autosomal dominant Alzheimer disease: Prevalence, genetic heterogeneity, and mutation spectrum
14. Conformational diseases
15. Alpha 1-antitrypsin deficiency: A model for conformational diseases
16. Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene
17. Excessive production of amyloid beta-protein by peripheral cells of symptomatic and presymptomatic patients carrying the Swedish familial Alzheimer disease mutation
18. Genetic predisposition to iatrogenic Creutzfeldt-Jakob disease
19. Molecular genetics of human prion diseases
20. Genetic evidence for the involvement of tau in progressive supranuclear palsy
21. Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease
22. Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid
23. Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: Implications for pathogenesis and therapy
24. Truncated N-terminal fragments of huntingtin with expanded glutamine repeats form nuclear and cytoplasmic aggregates in cell culture
25. malton
26. Synthetic filaments assembled from C-terminally truncated alpha-synuclein
27. Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion
28. Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes
29. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation
30. Are neuronal intranuclear inclusions the common neuropathology of triplet-repeat disorders with polyglutamine-repeat expansions?
31. Familial encephalopathy with neuroserpin inclusion bodies (FENIB)
32. Familial dementia caused by polymerization of mutant neuroserpin
33. Collins bodies and atypical myclonus bodies: The neuroserpin connection
34. Similar genetic susceptibility in iatrogenic and sporadic Creutzfeldt-Jakob disease
35. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain
36. Corticobasal degeneration shares a common genetic background with progressive supranuclear palsy
37. Linkage of the Indiana kindred of Gerstmann-Straussler-Scheinker disease to the prion protein gene
38. Pro - Leu change at position 102 of prion protein is the most common but not the sole mutation related to Gerstmann-Straussler syndrome
39. Inactivation of the mouse Huntington's disease gene homolog Hdh
40. Effects of the mutations Ala30 to Pro and Ala53 to Thr on the physical and morphological properties of alpha-synuclein protein implicated in Parkinson's disease
41. 1-antitrypsin
42. Transition-state analogue inhibitors of gamma-secretase bind directly to presenilin-1
43. Lewy bodies and parkinsonism in families with parkin mutations
44. Presenilin structure, function and role in Alzheimer disease
45. Mutation and polymorphism of the prion protein gene in Libyan Jews with Creutzfeldt-Jakob disease (CJD)
46. Inherited prion diseases
47. Mutant and wild type human alpha-synucleins assemble into elongated filaments with distinct morphologies in vitro
48. A hydrophobic stretch of 12 amino acid residues in the middle of alpha-synuclein is essential for filament assembly
49. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease
50. Tau gene mutations and neurodegeneration
51. Mutation in codon 200 of scrapie amyloid protein gene in two clusters of Creutzfeldt-Jakob disease in Slovakia
52. New mutation in scrapie amyloid precursor gene (at codon 178) in Finnish Creutzfeldt-Jakob kindred
53. Fatal familial insomnia and familial Creutzfeldt-Jakob disease: Disease phenotype determined by a DNA polymorphism
54. Mutations in familial Creutzfeldt-Jakob disease and Gerstmann-Straussler-Scheinker's syndrome
55. 1-antichymotrypsin indicates two stage insertion of the reactive loop; implications for inhibitory function and conformational disease
56. Formation of neurofibrillary tangles in P3011 tau transgenic mice induced by Abeta 42 fibrils
57. Nuclear and neuropil aggregates in Huntington's disease: Relationship to neuropathology
58. Renal amyloidosis with a frame shift mutation in fibrinogen aalpha-chain gene producing a novel amyloid protein
59. A novel apolipoprotein A-1 variant, Arg173Pro, associated with cardiac and cutaneous amyloidosis
60. Hereditary amyloid cardiomyopathy caused by a variant apolipoprotein A1
61. The molecular biology of Huntington's disease
62. Linkage of a prion protein missense variant to Gerstmann-Straussler syndrome
63. Mutation of the prion protein in Libyan Jews with Creutzfeldt-Jakob disease
64. Amyloid formation by mutant huntingtin: Threshold, progressivity and recruitment of normal polyglutamine proteins
65. 1-antitrypsin for structure and function of serpins
66. Structure of a serpin-protease complex shows inhibition by deformation
67. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes
68. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
69. Suppression of aggregate formation and apoptosis by transglutaminase inhibitors in cells expressing truncated DRPLA protein with an expanded polyglutamine stretch
70. Refined fibril structures: The hydrophobic core in Alzheimer's amyloid beta-protein and prion as revealed by X-ray diffraction
71. Characterization of the precursor protein of the non-A beta component of senile plaques (NACP) in the human central nervous system
72. Pathology of variant Creutzfeldt-Jakob disease
73. Human cystatin C, an amyloidogenic protein, dimerizes through three-dimensional domain swapping
74. Correlative light and electron microscopy studies of PrP localisation in 87V scrapie
75. Regulation of phospholipase D2: Selective inhibition of mammalian phospholipase D isoenzymes by alpha- and beta-synucleins
76. Binding of alpha-synuclein to brain vesicles is abolished by familial Parkinson's disease mutation
77. Increased beta-amyloid release and levels of amyloid precursor protein (APP) in fibroblast cell lines from family members with the Swedish Alzheimer's disease APP670/671 mutation
78. CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1
79. Novel missense variants of prion protein in Creutzfeldt-Jakob disease or Gerstmann-Straussler syndrome
80. Crystal structure of the human prion protein reveals a mechanism for oligomerization
81. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease
82. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy
83. 1-antitrypsin deficiency
84. The ubiquitin pathway in Parkinson's disease
85. Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type
86. Mutation in gelsolin gene in Finnish hereditary amyloidosis
87. Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP
88. Photoactivated gamma-secretase inhibitors directed to the active site covalently label presenilin 1
89. Antithrombin-TRI (Ala382 to Thr) causing severe thromboembolic tendency undergoes the S-to-R transition and is associated with a plasma-inactive high-molecular-weight complex of aggregated antithrombin
90. Solution structure of Syrian hamster prion protein rPrP(90-231)
91. 1-antitrypsin accumulation in the liver
92. iiyama (Ser53ØPhe). Further evidence for intracellular loop-sheet polymerization
93. 52Phe deleted) forms loop-sheet polymers in vivo: Evidence for the C sheet mechanism of polymerisation
94. Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red
95. Association between early-onset Parkinson's disease and mutations in the parkin gene
96. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice
97. Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregates
98. Familial Alzheimer's disease-linked mutations at Va717 of amyloid precursor protein are specific for the increased secretion of A beta 42(43)
99. Finnish hereditary amyloidosis is caused by a single nucleotide substitution in the gelsolin gene
100. A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid
101. A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease
102. Tau gene mutation G389R causes a tauopathy with abundant pick body-like inclusions and axonal deposits
103. Structure and expression of the gene responsible for the triplet repeat disorder, dentatorubral and pallidoluysian atrophy (DRPLA)
104. Both familial Parkinson's disease mutations accelerate α-synuclein aggregation
105. Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes
106. Pick's disease associated with the novel Tau gene mutation K369I
107. A mutation in apolipoprotein A-I in the Iowa type of familial amyloidotic polyneuropathy
108. The "Arctic" APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation
109. The new apolipoprotein A-I variant leu(174) → Ser causes hereditary cardiac amyloidosis, and the amyloid fibrils are constituted by the 93- residue N-terminal polypeptide
110. Ectopically expressed CAG repeats cause intranuclear inclusions and a progressive late onset neurological phenotype in the mouse
111. Mutation in the cystatin C gene causes hereditary brain hemorrhage
112. Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3
113. Human lysozyme gene mutations cause hereditary systemic amyloidosis
114. Hereditary nephropathic systemic amyloidosis caused by a novel variant apolipoprotein A-I
115. Glutamine repeats as polar zippers: Their possible role in inherited neurodegenerative diseases
116. Analysis of the prion protein gene in thalamic dementia
117. Neurodegeneration induced by beta-amyloid peptides in vitro: The role of peptide assembly state
118. Mutations in the α-synuclein gene identified in families with Parkinson's disease
119. Tau is a candidate gene for chromosome 17 frontotemporal dementia
120. NMR structure of the mouse prion protein domain PrP(121-231)
121. A new point mutation in the prion protein gene at codon 210 in Creutzfeldt-Jakob disease
122. Tau gene mutation K257T causes a tauopathy similar to Pick's disease
123. The role of prion peptide structure and aggregation in toxicity and membrane binding
124. Identification of the spinocerebellar ataxia type 2 gene using a direct identification of repeat expansion and cloning technique, DIRECT
125. Transthyretin mutations in hyperthyroxinemia and amyloid diseases
126. Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo
127. Secreted amyloid Β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease
128. Toward a comprehensive theory for Alzheimer's disease. Hypothesis: Alzheimer's disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein
129. Alzheimer's disease: Genes, proteins, and therapy
130. Alzheimer's amyloid fibrils: Structure and assembly
131. Fiber diffraction of synthetic alpha-synuclein filaments shows amyloid-like cross-beta conformation
132. 1-antitrypsin-deficient variant with mutation on a predicted conserved residue of the serpin backbone
133. Ubiquitination of a new form of alpha-synuclein by parkin from human brain: Implications for Parkinson's disease
134. The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature
135. 1-antitrypsin polymers are formed by reactive loop-Β-sheet A linkage
136. Apolipoprotein AI mutation Arg-60 causes autosomal dominant amyloidosis
137. Alpha-synuclein in Lewy bodies
138. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia
139. What do dysfunctional serpins tell us about molecular mobility and disease?
140. 1-antitrypsin deficiency in early childhood
141. Neuroserpin S52R mutation causes progressive myoclonus epilepsy and a wide distribution of intraneuronal neuroserpin deposits in the CNS
142. Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein
143. Hereditary renal amyloidosis with a novel variant fibrinogen
144. A frame shift mutation in the fibrinogen A alpha chain gene in a kindred with renal amyloidosis
145. Formation of stable complexes between two Alzheimer's disease gene products: Presenilin-2 and beta-amyloid precursor protein
146. Diagnosis of new variant Creutzfeldt-Jakob disease
147. Effects of heat shock, heat shock protein 40 (HDJ-2), and proteasome inhibition on protein aggregation in cellular models of Huntington's disease
148. Interaction between amyloid precursor protein and presenilins in mammalian cells: Implications for the pathogenesis of Alzheimer disease
149. Mechanisms of neuronal degeneration in Alzheimer's disease
150. Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue
151. Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel
152. Spinocerebellar ataxia type 1